Ophthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents.
Curr Opin Ophthalmol
; 31(5): 403-415, 2020 Sep.
Article
in English
| MEDLINE | ID: covidwho-692439
ABSTRACT
PURPOSE OF REVIEW To compile and report the ocular manifestations of coronavirus disease 2019 (COVID-19) infection and summarize the ocular side effects of investigational treatments of this disease. RECENT FINDINGS:
Conjunctivitis is by far the most common ocular manifestation of COVID-19 with viral particles being isolated from tears/secretions of infected individuals. Multiple therapeutic options are being explored across a variety of medication classes with diverse ocular side effects.SUMMARY:
Eye care professionals must exercise caution, as conjunctivitis may be the presenting or sole finding of an active COVID-19 infection. While no currently studied therapeutic agents have been found to reliably treat COVID-19, early vaccination trials are progressing and show promise. A video abstract is available for a more detailed summary. VIDEO ABSTRACT http//links.lww.com/COOP/A36.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Tears
/
Drugs, Investigational
/
Conjunctivitis, Viral
/
Coronavirus Infections
/
Drug-Related Side Effects and Adverse Reactions
/
Eye Diseases
/
Betacoronavirus
Type of study:
Diagnostic study
/
Experimental Studies
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Curr Opin Ophthalmol
Journal subject:
Ophthalmology
Year:
2020
Document Type:
Article
Affiliation country:
ICU.0000000000000682
Similar
MEDLINE
...
LILACS
LIS